Claudia Fehling

Senior Director, Regulatory at Nimbus Therapeutics

Role
Senior Director, Regulatory Affairs at Nimbus Therapeutics
Location
Boston, MA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Claudia Fehling

Accomplished regulatory affairs professional with 17 years of drug, biologic, and medical device regulatory experience• Regulatory Strategy Lead for INDs and CTAs and skilled in developing regulatory strategies to accelerate and de-risk product development• Guides strategic interactions and negotiations with Health Authorities• Successfully filed approximately 20 clinical trial applications (IND, CTA, or CTN), led approximately 30 health authority meetings, and filed Orphan Drug Designation (EU and US) and/or Fast Track Designation for over 15 products• Extensive experience with Orphan Drug and rare disease development programs as well as expedited development designations (Fast Track, Breakthrough Therapy, and Accelerated Approval Endpoints)• Experience spans small molecules, oligonucleotides, mAbs, therapeutic proteins, live biotherapeutics, vaccines, medical devices, and combination products across indications including neurology, oncology, immunology, antiviral, hepatology, gastroenterology, pulmonary, nephrology, endocrinology, metabolism, musculoskeletal, and urology

Experience

  1. Senior Director, Regulatory Affairs

    Nimbus Therapeutics

    Nov 2024 — Present · Boston, MA, US

Education

  • Davidson College

    BS, Biology

  • Johns Hopkins Bloomberg School of Public Health

    Master of Public Health (MPH)

Skills

  • Clinical Trials
  • Quality System
  • Pharmaceutical Industry
  • Sop
  • Fda
  • Science
  • Quality Control
  • Gmp
  • Regulatory Requirements
  • Quality Assurance
  • Glp
  • Oncology
  • Gcp
  • Biopharmaceuticals
  • U.s. Food and Drug Administration (Fda)
  • Healthcare
  • Biotechnology
  • Regulatory Submissions
  • Clinical Development
  • Technology Transfer
  • Gxp
  • Life Sciences
  • Quality Auditing
  • 21 Cfr Part 11
  • Medical Devices
  • Clinical Research
  • Iso 13485
  • Regulatory Affairs
  • Lifesciences

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Claudia Fehling — Senior Director, Regulatory Affairs at Nimbus Therapeutics in Boston, MA, US | Unifers